Advertisement
Chemoprevention and Biological Therapies

Abstract B34: NOSH-aspirin (NBS-1120) a dual nitric oxide and hydrogen sulfide releasing hybrid for treatment of cancer

Mitali Chattopadhyay, Ravinder Kodela, Diana H. Lee, Thuy-Tien C. Le and Khosrow Kashfi
DOI: 10.1158/1940-6207.PREV-12-B34 Published November 2012

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: January 2014 to June 2020

AbstractFull-text HTMLPDF
Total124700

Cited By

Article Information

Volume 5, Issue 11 Supplement, pp. B34

DOI 
https://doi.org/10.1158/1940-6207.PREV-12-B34
Published By 
American Association for Cancer Research
Print ISSN 
1940-6207
Online ISSN 
1940-6215
History 
  • Published first January 23, 2014.
Copyright & Usage 
©2012 American Association for Cancer Research.

Author Information

  1. Mitali Chattopadhyay1,
  2. Ravinder Kodela1,
  3. Diana H. Lee1,
  4. Thuy-Tien C. Le2, and
  5. Khosrow Kashfi1
  1. 1City University of New York Medical School, New York, NY, 2New York Institute of Technology, New York, NY.
Back to top
Cancer Prevention Research: 5 (11 Supplement)
November 2012
Volume 5, Issue 11 Supplement

Sign up for alerts

Article Alerts
Email Article
Citation Tools
Abstract B34: NOSH-aspirin (NBS-1120) a dual nitric oxide and hydrogen sulfide releasing hybrid for treatment of cancer
Mitali Chattopadhyay, Ravinder Kodela, Diana H. Lee, Thuy-Tien C. Le and Khosrow Kashfi
Cancer Prev Res November 1 2012 (5) (11 Supplement) B34; DOI: 10.1158/1940-6207.PREV-12-B34
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo

Jump to section

Advertisement